Microba Life Sciences Limited (ASX:MAP) Insider Acquires A$34,200.00 in Stock

Microba Life Sciences Limited (ASX:MAP) insider Pasquale (Paddy) Rombola bought 200,000 shares of the business’s stock in a transaction on Tuesday, November 19th. The shares were acquired at an average cost of A$0.17 ($0.11) per share, with a total value of A$34,200.00 ($22,352.94).

Microba Life Sciences Stock Performance

The company has a debt-to-equity ratio of 3.84, a quick ratio of 6.50 and a current ratio of 2.61.

Microba Life Sciences Company Profile

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.